Announcements

Announcements

Paul G. Allen Frontiers Group [to 8 Jun 2019]
https://alleninstitute.org/what-we-do/frontiers-group/news-press/
No new digest content identified.

BMGF – Gates Foundation [to 8 Jun 2019]
http://www.gatesfoundation.org/Media-Center/Press-Releases
No new digest content identified.

Bill & Melinda Gates Medical Research Institute [to 8 Jun 2019]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.

CARB-X [to 8 Jun 2019]
https://carb-x.org/
CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria.
No new digest content identified.

CEPI – Coalition for Epidemic Preparedness Innovations [to 8 Jun 2019]
http://cepi.net/
04 Jun 2019
The world needs a Chikungunya vaccine
By Richard Hatchett
Over a billion people live in areas where Chikungunya is endemic. We urgently need a vaccine against this disease.

04 Jun 2019
CEPI awards up to US$21 million to Themis Bioscience for Phase 3 Chikungunya Vaccine Development
Vienna, Austria, and Oslo, Norway, June 4, 2019—Themis Bioscience and the Coalition for Epidemic Preparedness Innovations (CEPI) announced a second partnering agreement under which CEPI, with support from the European Union’s (EU’s) Horizon 2020 programme, will provide up to US$21 million of non-dilutive capital* for Themis’ Phase 3-ready Chikungunya vaccine (MV-CHIK). The funding will underwrite a collaborative effort to accelerate regulatory approval of Themis’ Chikungunya vaccine and ensure that at-risk populations have access to the vaccine. The agreement will provide a significant portion of the capital required for Themis’ Phase 3 clinical trial. Clinical trial applications will be submitted to regulatory authorities in the second half of 2019, with the trial initiation expected shortly thereafter. The pivotal multi-center Phase 3 trial will be launched in Europe, US and the Americas and will also test a single-shot regimen…

Clinton Health Access Initiative, Inc. (CHAI) [to 8 Jun 2019]
https://clintonhealthaccess.org/about/
No new digest content identified.

EDCTP [to 8 Jun 2019]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
No new digest content identified.

Emory Vaccine Center [to 8 Jun 2019]
http://www.vaccines.emory.edu/
No new digest content identified.

European Medicines Agency [to 8 Jun 2019]
http://www.ema.europa.eu/ema/
News and press releases
No new digest content identified.

European Vaccine Initiative [to 8 Jun 2019]
http://www.euvaccine.eu/news-events
No new digest content identified.

FDA [to 8 Jun 2019]
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
No new digest content identified.

Fondation Merieux [to 8 Jun 2019]
http://www.fondation-merieux.org/
Christophe Mérieux Prize
Maryline Bonnet receives the 2019 Christophe Mérieux Prize for her research on tuberculosis in developing countries
June 6, 2019, Paris (France)
The 2019 Christophe Mérieux Prize was awarded by Fondation Christophe et Rodolphe Mérieux of the Institut de France to Maryline Bonnet on Wednesday June 5th under the dome of the Institut de France. The pulmonologist and research director in Uganda was awarded for her tuberculosis research program in developing countries.

Gavi [to 8 Jun 2019]
https://www.gavi.org/
06 June 2019
Gavi, NEC, and Simprints to deploy world’s first scalable child fingerprint identification solution to boost immunisation in developing countries
Gavi, the Vaccine Alliance, NEC Corporation, and Simprints Technology Ltd. have signed a memorandum of understanding on the use of biometrics to improve immunisation coverage in developing countries.
Despite enormous progress over the past two decades, there are still approximately 20 million children who do not receive a basic course of vaccines worldwide, leaving them exposed to some of the world’s deadliest diseases.

One key cause is the fact that only half of all children under 5 in sub-Saharan Africa are currently registered at birth, leaving many without an official identity. This makes it difficult for health practitioners to ensure these infants get the vaccines they need at the right time.
Guided by Gavi’s experience and expertise in immunisation, this new project will combine Simprints’ biometric fingerprint technology and NEC’s reinforced authentication engine to help create digital identities for children 1-5 years of age and boost immunisation coverage in developing countries.

This new partnership will deploy the world’s first scalable fingerprint identification solution to give children aged 1-5 a digital ID linked to an accurate, complete medical record. All biometric records will be stored securely by Simprints, a UK-based non-profit social enterprise, after caregivers give informed consent to having their children’s biometric data taken…

GHIT Fund [to 8 Jun 2019]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that devastate the world’s poorest people. Other funders include six Japanese pharmaceutical
No new digest content identified.

Global Fund [to 8 Jun 2019]
https://www.theglobalfund.org/en/news/
Feature Story
Global Fund Data Explorer
05 June 2019
Visualize Global Fund Investments and Results through the new Data Explorer

News
Takeda Makes First Private Sector Pledge for Global Fund Replenishment
03 June 2019
OSAKA/GENEVA – Takeda Pharmaceutical Company Limited today became the first private sector company to announce a financial commitment to the Global Fund’s Sixth Replenishment. The new pledge, consisting of JP ¥ 1 billion (approximately US$9 million) over five years, builds on Takeda’s previous contribution to the Global Fund…

Hilleman Laboratories [to 8 Jun 2019]
http://www.hillemanlabs.org/
No new digest content identified.

Human Vaccines Project [to 8 Jun 2019]
http://www.humanvaccinesproject.org/media/press-releases/
No new digest content identified.

IAVI [to 8 Jun 2019]
https://www.iavi.org/newsroom
No new digest content identified.

 

IFFIm
http://www.iffim.org/library/news/press-releases/
No new digest content identified.

IFRC [to 8 Jun 2019]
http://media.ifrc.org/ifrc/news/press-releases/
Selected Press Releases, Announcements
Italy
Global youth gathering of thousands to celebrate 100 years of world’s largest humanitarian network
Geneva/Rome, 6 June 2019 – More than 10,000 young Red Cross and Red Crescent leaders and volunteers from 140 countries will gather in northern Italy from 17-23 June to celebrate the centenary of the International Federation of Red Cross and Red Crescen …

IVAC [to 8 Jun 2019]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
No new digest content identified.

IVI [to 8 Jun 2019]
http://www.ivi.int/
IVI News & Announcements
No new digest content identified.

JEE Alliance [to 8 Jun 2019]
https://www.jeealliance.org/
Selected News and Events
No new digest content identified.

MSF/Médecins Sans Frontières [to 8 Jun 2019]
http://www.msf.org/
Selected News; Project Updates, Reports
El Salvador
Behind the wheel – driving ambulances in El Salvador’s red zones
Voices from the Field 7 Jun 2019

Pakistan
Witnessing poor mother and child healthcare in Balochistan
Project Update 6 Jun 2019

Iran
Providing health care to vulnerable people in Lorestan after floods i…
Project Update 6 Jun 2019

Yemen
Endemic in Yemen, cholera still hits Yemenis hard
Project Update 5 Jun 2019

NIH [to 8 Jun 2019]
http://www.nih.gov/news-events/news-releases
June 6, 2019
NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
— Scientists explain vision for the future of ART in JAMA commentary.

Immune cells play unexpected role in early tuberculosis infection
June 5, 2019 — NIH-supported discovery may provide a new target for TB drugs, vaccines.

NIH-supported study reveals a novel indicator of influenza immunity
June 3, 2019 — Findings could help scientists design more effective influenza vaccines and lead to the development of novel universal influenza vaccines.

PATH [to 8 Jun 2019]
https://www.path.org/media-center/
June 3, 2019 by PATH
PATH and Sinapi Biomedical launch lifesaving medical device to combat postpartum hemorrhage
Ellavi—the first commercially available, low-cost, fully assembled uterine balloon tamponade—receives internationally-recognized CE marking

Sabin Vaccine Institute [to 8 Jun 2019]
http://www.sabin.org/updates/pressreleases
No new digest content identified.

UNAIDS [to 8 Jun 2019]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
5 June 2019
Malawi: remember where we have come from to move forward

5 June 2019
Young women demand accountability at Women Deliver

4 June 2019
Chisinau signs the Paris Declaration
Ruslan Codrenu, the Acting Mayor of Chisinau, Republic of Moldova, signed the Paris Declaration to end the AIDS epidemic in cities on 31 May. He committed the city to achieving the 90–90–90 targets by 2020, whereby 90% of all people living with HIV know their HIV status, 90% of people who know their HIV-positive status are on treatment and 90% of people on treatment have suppressed viral loads. The city will specifically focus on marginalized and vulnerable people and on ending stigma and discrimination.’’…

3 June 2019
Changing the lives of transgender people in Malawi

3 June 2019
TB-related deaths among people living with HIV falling, but not by enough
Even though tuberculosis (TB) is preventable and curable, it is the top infectious killer worldwide, claiming around 4400 lives a day. TB also remains the leading cause of death among people living with HIV, causing one in three AIDS-related deaths. However, progress has been made―TB-related deaths among people living with HIV peaked in 2005, at 600 000 deaths; since then, they have halved, to 300 000 in 2017…

UNICEF [to 8 Jun 2019]
https://www.unicef.org/media/press-releases
Selected Statements, Press Releases, Reports
Press release
UNICEF ramps up humanitarian assistance to children in Venezuela, delivers 55 tons of health supplies since January
3.2 million children – or 1 in 3 – need assistance
07/06/2019

Press release
Pocket-sized innovation, giant impact: New app and online system launches in South Sudan to support most vulnerable children
The innovations will support case workers helping unaccompanied and separated children, child survivors of sexual violence, and children associated with armed groups.
06/06/2019

Press release
115 million boys and men around the world married as children – UNICEF
First ever analysis on child grooms brings global child marriage figures to 765 million
06/06/2019

Press release
New Dove and UNICEF partnership to reach 10 million young people with essential self-esteem and body confidence education
05/06/2019

Press release
Only 6 per cent of children in Africa live in areas where air pollution is reliably measured at the ground-level
More reliable ground-level measurements are required to combat this silent killer of children, particularly in Africa where the problem is growing and gravely under-studied
04/06/2019

Press release
World not delivering quality maternal health care to poorest mothers – UNICEF
Millions of mothers at risk due to prohibitive health care costs, lack of access to services and skilled professionals, and child marriage
03/06/2019

Vaccine Confidence Project [to 8 Jun 2019]
http://www.vaccineconfidence.org/
No new digest content identified.

Vaccine Education Center – Children’s Hospital of Philadelphia [to 8 Jun 2019]
http://www.chop.edu/centers-programs/vaccine-education-center
No new digest content identified.

Wellcome Trust [to 8 Jun 2019]
https://wellcome.ac.uk/news
Opinion | 6 June 2019
New funding model to replace the Public Engagement Fund
Imran Khan, Greer Roberts, Public Engagement team – Wellcome
This autumn we’ll be announcing new partnerships that will allocate funding to innovative public engagement projects. To allow us to do so, we’re closing the Public Engagement Fund.

The Wistar Institute [to 8 Jun 2019]
https://www.wistar.org/news/press-releases
Press Release Jun. 3, 2019
University Place Associates and The Wistar Institute Collaborate to Create New Research and Discovery Hub in Philadelphia’s University City District
Allows for establishment of collaborations among Wistar and academic research and biotechnology start-up communities in the region.

World Organisation for Animal Health (OIE) [to 8 Jun 2019]
http://www.oie.int/en/for-the-media/press-releases/2019/
No new digest content identified.

 

::::::

BIO [to 8 Jun 2019]
https://www.bio.org/insights/press-release
Jun 5 2019
BIO Applauds House Passage of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act
The Biotechnology Innovation Organization (BIO) applauds members of the House of Representatives for passing the Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPAI) of 2019.

DCVMN – Developing Country Vaccine Manufacturers Network [to 8 Jun 2019]
http://www.dcvmn.org/
No new digest content identified.

IFPMA [to 8 Jun 2019]
http://www.ifpma.org/resources/news-releases/
No new digest content identified.

PhRMA [to 8 Jun 2019]
http://www.phrma.org/press-room
No new digest content identified.

Journal Watch

Journal Watch
Vaccines and Global Health: The Week in Review continues its weekly scanning of key peer-reviewed journals to identify and cite articles, commentary and editorials, books reviews and other content supporting our focus on vaccine ethics and policy. Journal Watch is not intended to be exhaustive, but indicative of themes and issues the Center is actively tracking. We selectively provide full text of some editorial and comment articles that are specifically relevant to our work. Successful access to some of the links provided may require subscription or other access arrangement unique to the publisher.
If you would like to suggest other journal titles to include in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org

On the Ground in Malawi—First Typhoid Conjugate Vaccine Study in Africa

American Journal of Tropical Medicine and Hygiene
Volume 100, Issue 6, 2019
http://www.ajtmh.org/content/journals/14761645/100/6

 

Stories from the Field
On the Ground in Malawi—First Typhoid Conjugate Vaccine Study in Africa
Pratiksha Patel, Priyanka Patel, James E. Meiring, Theresa Misiri, Felistas Mwakiseghile and Melita A. Gordon
https://doi.org/10.4269/ajtmh.19-0014

Immigrant health access in Texas: policy, rhetoric, and fear in the Trump era

BMC Health Services Research
http://www.biomedcentral.com/bmchealthservres/content
(Accessed 8 Jun 2019)

 

Research article
Immigrant health access in Texas: policy, rhetoric, and fear in the Trump era
Since the 2016 presidential election, reports have suggested that President Trump’s rhetoric and his administration’s proposed policies could be exacerbating barriers to accessing health care for undocumented …
Authors: Timothy Callaghan, David J. Washburn, Katharine Nimmons, Delia Duchicela, Anoop Gurram and James Burdine
Citation: BMC Health Services Research 2019 19:342
Published on: 5 June 2019

A decade of sustained geographic spread of HIV infections among women in Durban, South Africa

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 8 Jun 2019)

 

Research article
A decade of sustained geographic spread of HIV infections among women in Durban, South Africa
Fine scale geospatial analysis of HIV infection patterns can be used to facilitate geographically targeted interventions. Our objective was to use the geospatial technology to map age and time standardized HIV…
Authors: Gita Ramjee, Benn Sartorius, Natashia Morris, Handan Wand, Tarylee Reddy, Justin D. Yssel and Frank Tanser
Citation: BMC Infectious Diseases 2019 19:500
Published on: 7 June 2019

Mapping evidence of intervention strategies to improving men’s uptake to HIV testing services in sub-Saharan Africa: A systematic scoping review

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 8 Jun 2019)

 

Research article
Mapping evidence of intervention strategies to improving men’s uptake to HIV testing services in sub-Saharan Africa: A systematic scoping review
HIV testing serves as a critical gateway for linkage and retention to care services, particularly in sub-Saharan African countries with high burden of HIV infections. However, the current progress towards addr…
Authors: Mbuzeleni Hlongwa, Tivani Mashamba-Thompson, Sizwe Makhunga and Khumbulani Hlongwana
Citation: BMC Infectious Diseases 2019 19:496
Published on: 6 June 2019

Huge variation in obtaining ethical permission for a non-interventional observational study in Europe

BMC Medical Ethics
http://www.biomedcentral.com/bmcmedethics/content
(Accessed 8 Jun 2019)

 

Research article
|   3 June 2019
Huge variation in obtaining ethical permission for a non-interventional observational study in Europe
Ethical approval (EA) must be obtained before medical research can start. We describe the differences in EA for an pseudonymous, non-interventional, observational European study.
Authors: Dylan W. de Lange, Bertrand Guidet, Finn H. Andersen, Antonio Artigas, Guidio Bertolini, Rui Moreno, Steffen Christensen, Maurizio Cecconi, Christina Agvald-Ohman, Primoz Gradisek, Christian Jung, Brian J. Marsh, Sandra Oeyen, Bernardo Bollen Pinto, Wojciech Szczeklik, Ximena Watson…

A survey in Mexico about ethics dumping in clinical research

BMC Medical Ethics
http://www.biomedcentral.com/bmcmedethics/content
(Accessed 8 Jun 2019)

 

Research article
|   3 June 2019
A survey in Mexico about ethics dumping in clinical research
The exportation of unethical practices to low- and middle-income countries (“Ethics Dumping”) has been conceived as a prevalent practice which needs to be examined more closely. Such a practice might point towards the exploitation of vulnerable population groups. We conducted a survey among Mexican research ethics committee members to explore the issue of ethics dumping in Mexico by understanding how its existence and contributing factors and norms are perceived by these ethics committee members.
Authors: Novoa-Heckel Germán and Bernabe Rosemarie

Conditional cash transfers to improve use of health facilities by mothers and newborns in conflict affected countries, a prospective population based intervention study from Afghanistan

BMC Pregnancy and Childbirth
http://www.biomedcentral.com/bmcpregnancychildbirth/content
(Accessed 8 Jun 2019)

 

Research article
Conditional cash transfers to improve use of health facilities by mothers and newborns in conflict affected countries, a prospective population based intervention study from Afghanistan
The effects of conditional cash transfer (CCT) programs on maternal and child health (MCH) service use in conflicted affected countries such as Afghanistan are not known.
Authors: Karen M. Edmond, Abo Ishmael Foshanji, Malalai Naziri, Ariel Higgins-Steele, Jane Machlin Burke, Natalie Strobel and Farhad Farewar
Citation: BMC Pregnancy and Childbirth 2019 19:193
Published on: 3 June 2019

Monitoring progress towards the elimination of measles in Iran: supporting evidence from 2014 to 2016 by application of measles outbreaks data

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 8 Jun 2019)

 

Research article
Monitoring progress towards the elimination of measles in Iran: supporting evidence from 2014 to 2016 by application of measles outbreaks data
To achieve the goal of measles eradication, all WHO member countries should continuously monitor the status of measles elimination. This work aims to characterize measles outbreaks in Iran from 2014 to 2016 an…
Authors: Naser Piri, Manoochehr Karami, Leili Tapak, Seyed Mohsen Zahraei and Younes Mohammadi
Citation: BMC Public Health 2019 19:687
Published on: 3 June 2019

Maternal Immunization and Antenatal Care Situation Analysis (MIACSA) study protocol: a multiregional, cross-sectional analysis of maternal immunization delivery strategies to reduce maternal and neonatal morbidity and mortality

BMJ Open
June 2019 – Volume 9 – 6
http://bmjopen.bmj.com/content/current

 

Article
Maternal Immunization and Antenatal Care Situation Analysis (MIACSA) study protocol: a multiregional, cross-sectional analysis of maternal immunization delivery strategies to reduce maternal and neonatal morbidity and mortality (4 June, 2019)
Nathalie Roos, Philipp Lambach, Carsten Mantel, Elizabeth Mason, Flor M Muñoz, Michelle Giles, Allisyn Moran, Joachim Hombach, Theresa Diaz

“Just keep pushing”: Parents’ experiences of accessing child and adolescent mental health services for child anxiety problems

Child Care, Health and Development
Volume 45, Issue 4 Pages: 473-612 July 2019
https://onlinelibrary.wiley.com/toc/13652214/current

 

RESEARCH ARTICLES
“Just keep pushing”: Parents’ experiences of accessing child and adolescent mental health services for child anxiety problems
Lauren Crouch,Tessa Reardon, Alice Farrington, Frankie Glover, Cathy Creswell
Pages: 491-499
First Published: 16 April 2019

Predictors of posttraumatic growth among conflict-related sexual violence survivors from Bosnia and Herzegovina

Conflict and Health
http://www.conflictandhealth.com/
[Accessed 8 Jun 2019]

 

Research
|   4 June 2019
Predictors of posttraumatic growth among conflict-related sexual violence survivors from Bosnia and Herzegovina
Authors: Kimberley Anderson, Amra Delić, Ivan Komproe, Esmina Avdibegović, Elisa van Ee and Heide Glaesmer

‘We just been forced to do it’: exploring victimization and agency among internally displaced young mothers in Bogotá

Conflict and Health
http://www.conflictandhealth.com/
[Accessed 8 Jun 2019]

 

Research
|   3 June 2019
‘We just been forced to do it’: exploring victimization and agency among internally displaced young mothers in Bogotá
Authors: Yazmin Cadena-Camargo, Anja Krumeich, Maria Claudia Duque-Páramo and Klasien Horstman

How do Chinese universities address research integrity and misconduct? A review of university documents

Developing World Bioethics
Volume 19, Issue 2 Pages: 61-122 June 2019
https://onlinelibrary.wiley.com/toc/14718847/current

 

COUNTRY REPORT
How do Chinese universities address research integrity and misconduct? A review of university documents
Nannan Yi, Benoit Nemery, Kris Dierickx
Pages: 64-75
First Published: 15 May 2019
ABSTRACT
Background
Scientific researchers are expected to follow the professional norms in their own domain. With a growing number of scientific publications retracted and research misconduct cases revealed in recent years, Chinese biomedical research integrity is questioned. As institutions educating and training future researchers, universities and the guidance they provide are important for the research quality and integrity of the country. Therefore, through a review of the guidance and policy documents on research integrity in Chinese universities, this work aims to investigate how the professional norms are specified in these documents.
Methods
After a stratified sampling, 53 universities were selected. Their guidance and policy documents on research integrity were collected via a web search of their official websites. The search was confirmed by these universities. Then the content of all the collected documents were analyzed using inductive content analysis.
Results
118 active university documents were collected and analyzed. Most of the Chinese universities we investigated had their own guidance or policy on research integrity. They listed principles or examples of desired and undesired academic practices, investigation procedures and punishments of academic misconduct, and put forward measures to promote research integrity. Differences on specific practices and principles were observed between university groups and with European university documents.
Conclusion
Despite the discrepancy they have, all these documents were designed to promote research integrity and cultivate a good research environment in Chinese biomedical domain. Nevertheless, there is still room for improvement, for example, through more consultation of international guidance.

Considerations for community engagement when conducting clinical trials during infectious disease emergencies in West Africa

Developing World Bioethics
Volume 19, Issue 2 Pages: 61-122 June 2019
https://onlinelibrary.wiley.com/toc/14718847/current

 

ORIGINAL ARTICLE
Considerations for community engagement when conducting clinical trials during infectious disease emergencies in West Africa
Morenike Oluwatoyin Folayan, Dan Allman, Bridget Haire, Aminu Yakubu, Muhammed O. Afolabi, Joseph Cooper
Pages: 96-105
First Published: 15 November 2018
Abstract
Community engagement in research, including public health related research, is acknowledged as an ethical imperative. While medical care and public health action take priority over research during infectious disease outbreaks, research is still required in order to learn from epidemic responses. The World Health Organisation developed a guide for community engagement during infectious disease epidemics called the Good Participatory Practice for Trials of Emerging (and Re‐emerging) Pathogens that are Likely to Cause Severe Outbreaks in the Near Future and for which Few or No Medical Counter‐Measures Exist (GPP‐EP). This paper identified priorities for community engagement for research conducted during infectious disease outbreaks drawing on discussions held with a purposive sample of bioethicists, social scientists, researchers, policy makers and laypersons who work with ethics committees in West Africa. These perspectives were considered in the light of the GPP‐EP, which adds further depth and dimension to discussions on community engagement frameworks. It concludes that there is no presumptive justification for the exclusion of communities in the design, implementation and monitoring of clinical trials conducted during an infectious disease outbreak. Engagement that facilitates collaboration rather than partnership between researchers and the community during epidemics is acceptable.

The international partner universities of East African health professional programmes: why do they do it and what do they value?

Globalization and Health
http://www.globalizationandhealth.com/
[Accessed 24 Nov 2018]

 

Research
|   7 June 2019
The international partner universities of East African health professional programmes: why do they do it and what do they value?
Globalization and funding imperatives drive many universities to internationalize through global health programmes. University-based global health researchers, advocates and programmes often stress the importance of addressing health inequity through partnerships. However, empirical exploration of perspectives on why universities engage in these partnerships and the benefits of them is limited.
Authors: Aaron N. Yarmoshuk, Donald C. Cole, Anastasia Nkatha Guantai, Mughwira Mwangu and Christina Zarowsky

Special Feature: Making humanitarian action work for women and girls

Humanitarian Exchange Magazine
Number 75, May 2019
https://odihpn.org/magazine/communication-community-engagement-humanitarian-response/

 

Special Feature: Making humanitarian action work for women and girls
by HPN May 2019
The theme of this edition of Humanitarian Exchange, co-edited with Women Deliver, is making humanitarian action work for women and girls. Despite gains, including commitments made at the World Humanitarian Summit, there is still much to be done to address the gendered impacts of humanitarian crises and improve gender-sensitive humanitarian action.

In the lead article, Jacqueline Paul advocates for feminist humanitarian action based on evidence that improvements in women’s socio-economic status can reduce excess mortality among women after shocks. Jean Kemitare, Juliet Were and Jennate Eoomkham look at the role of local women’s rights organisations in preventing and responding to violence against women and girls, and Marcy Hersh and Diana Abou Abbas highlight opportunities for more concrete action on sexual and reproductive health in emergencies.

Citing experience from Vanuatu, Jane Newnham explains how women will choose to use contraceptives even during a humanitarian response, when services and counselling are delivered in an appropriate and responsive way. Drawing on experience in Bangladesh, Tamara Fetters and colleagues challenge the belief that abortion is a non-essential service, or too complicated for humanitarian actors to provide. Darcy Ataman, Shannon Johnson, Justin Cikuru and Jaime Cundy reflect on an innovative programme using music therapy to help survivors of trauma.

Emilie Rees Smith, Emma Symonds and Lauryn Oates highlight lessons from the STAGE education programme in Afghanistan, and Degan Ali and Deqa Saleh outline how African Development Solutions is helping women and girls take on leadership and decision-making roles in Somalia. Fiona Samuels and Taveeshi Gupta explore patterns of suicide among young people in Vietnam, with a particular focus on girls, and Subhashni Raj, Brigitte Laboukly and Shantony Moli illustrate the importance of a gendered approach to community-based disaster risk reduction in the South-West Pacific. Nicola Jones, Workneh Yadete and Kate Pincock draw on research in Ethiopia to explore the gender- and age-specific vulnerabilities of adolescents. The edition ends with an article by Julie Rialet-Cislaghi on how humanitarian responses can better address child marriage.

pecial Feature: Making humanitarian action work for women and girls

Humanitarian Exchange Magazine
Number 75, May 2019
https://odihpn.org/magazine/communication-community-engagement-humanitarian-response/

 

Special Feature: Making humanitarian action work for women and girls
by HPN May 2019
The theme of this edition of Humanitarian Exchange, co-edited with Women Deliver, is making humanitarian action work for women and girls. Despite gains, including commitments made at the World Humanitarian Summit, there is still much to be done to address the gendered impacts of humanitarian crises and improve gender-sensitive humanitarian action.

In the lead article, Jacqueline Paul advocates for feminist humanitarian action based on evidence that improvements in women’s socio-economic status can reduce excess mortality among women after shocks. Jean Kemitare, Juliet Were and Jennate Eoomkham look at the role of local women’s rights organisations in preventing and responding to violence against women and girls, and Marcy Hersh and Diana Abou Abbas highlight opportunities for more concrete action on sexual and reproductive health in emergencies.

Citing experience from Vanuatu, Jane Newnham explains how women will choose to use contraceptives even during a humanitarian response, when services and counselling are delivered in an appropriate and responsive way. Drawing on experience in Bangladesh, Tamara Fetters and colleagues challenge the belief that abortion is a non-essential service, or too complicated for humanitarian actors to provide. Darcy Ataman, Shannon Johnson, Justin Cikuru and Jaime Cundy reflect on an innovative programme using music therapy to help survivors of trauma.

Emilie Rees Smith, Emma Symonds and Lauryn Oates highlight lessons from the STAGE education programme in Afghanistan, and Degan Ali and Deqa Saleh outline how African Development Solutions is helping women and girls take on leadership and decision-making roles in Somalia. Fiona Samuels and Taveeshi Gupta explore patterns of suicide among young people in Vietnam, with a particular focus on girls, and Subhashni Raj, Brigitte Laboukly and Shantony Moli illustrate the importance of a gendered approach to community-based disaster risk reduction in the South-West Pacific. Nicola Jones, Workneh Yadete and Kate Pincock draw on research in Ethiopia to explore the gender- and age-specific vulnerabilities of adolescents. The edition ends with an article by Julie Rialet-Cislaghi on how humanitarian responses can better address child marriage.

Use of adjuvanted trivalent influenza vaccine in older-age adults: a systematic review of economic evidence

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 15, Issue 5, 2019
http://www.tandfonline.com/toc/khvi20/current

 

Review
Use of adjuvanted trivalent influenza vaccine in older-age adults: a systematic review of economic evidence
Ilaria Loperto, Andrea Simonetti, Antonio Nardone & Maria Triassi
Pages: 1035-1047
Published online: 25 Mar 2019

Improving influenza vaccination uptake among healthcare workers by on-site influenza vaccination campaign in a tertiary children hospital

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 15, Issue 5, 2019
http://www.tandfonline.com/toc/khvi20/current

 

Article
Improving influenza vaccination uptake among healthcare workers by on-site influenza vaccination campaign in a tertiary children hospital
Melahat Melek Oguz
Pages: 1060-1065
Published online: 19 Mar 2019

Knowledge about influenza and adherence to the recommendations for influenza vaccination of pregnant women after an educational intervention in Greece

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 15, Issue 5, 2019
http://www.tandfonline.com/toc/khvi20/current

 

Article
Knowledge about influenza and adherence to the recommendations for influenza vaccination of pregnant women after an educational intervention in Greece
Helena C. Maltezou, Pelopidas Pelopidas Koutroumanis, Chrissa Kritikopoulou, Kalliopi Theodoridou, Panos Katerelos, Ioanna Tsiaousi, Alexandros Rodolakis & Dimitrios Loutradis
Pages: 1070-1074
Published online: 20 Feb 2019

Reliability and validity of a survey to identify vaccine hesitancy among parents in Changxing county, Zhejiang province

Human Vaccines & Immunotherapeutics (formerly Human Vaccines)
Volume 15, Issue 5, 2019
http://www.tandfonline.com/toc/khvi20/current

 

Article
Reliability and validity of a survey to identify vaccine hesitancy among parents in Changxing county, Zhejiang province
Yu Hu, Yaping Chen, Hui Liang & Ying Wang
Pages: 1092-1099
Published online: 19 Mar 2019

First report of a persistent oropharyngeal infection of type 2 vaccine-derived poliovirus (iVDPV2) in a primary immune deficient (PID) patient after eradication of wild type 2 poliovirus

International Journal of Infectious Diseases
June 2019 Volume 83, p1-170
https://www.ijidonline.com/issue/S1201-9712(19)X0008-9

 

Case Reports
First report of a persistent oropharyngeal infection of type 2 vaccine-derived poliovirus (iVDPV2) in a primary immune deficient (PID) patient after eradication of wild type 2 poliovirus
Merav Weil, Galia Rahav, Raz Somech, Tali Stauber, Jacqueline Alfandari, Leah Weiss, Ilana Silberstein, Victoria Indenbaum, Itay Bar Or, Ella Mendelson, Danit Sofer, Lester M. Shulman
p40–43

The Importance of Predefined Rules and Prespecified Statistical AnalysesDo Not Abandon Significance

JAMA
June 4, 2019, Vol 321, No. 21, Pages 2045-2142
http://jama.jamanetwork.com/issue.aspx

 

Viewpoint
The Importance of Predefined Rules and Prespecified Statistical AnalysesDo Not Abandon Significance
John P. A. Ioannidis, MD, DSc
JAMA. 2019;321(21):2067-2068. doi:10.1001/jama.2019.4582

In this Viewpoint, John Ioannidis argues against abandoning the notion and language of statistical significance, which has been proposed as a means to diminish oversimplistic interpretations of clinical research. A significance filter in some form is essential for distinguishing signal from noise, he writes, and emphasizes that predefined study design choices, prespecified statistical analyses, transparent and documented deviations from either, and improvement in researchers’ statistical numeracy can minimize overly subjective interpretations of whatever significance measure is used.

Global Health Spending and Development Assistance for Health

JAMA
June 4, 2019, Vol 321, No. 21, Pages 2045-2142
http://jama.jamanetwork.com/issue.aspx

 

Global Health Spending and Development Assistance for Health
Joseph L. Dieleman, PhD; Angela E. Micah, PhD; Christopher J. L. Murray, MD, DPhil
JAMA. 2019;321(21):2073-2074. doi:10.1001/jama.2019.3687
mmmThis Viewpoint reviews the global health role of development assistance for health (DAH) and financial or in-kind assistance provided by western countries via international development agencies and foundations to low- and middle-income countries (LMICs), and proposes best practices to ensure that DAH continues to be a reliable source of support for LMIC health systems and assists them to develop pandemic preparedness.

Duration of Immunity and Effectiveness of Diphtheria-Tetanus–Acellular Pertussis Vaccines in Children

JAMA Pediatrics
June 2019, Vol 173, No. 6, Pages 509-610
http://archpedi.jamanetwork.com/issue.aspx

 

Original Investigation
Duration of Immunity and Effectiveness of Diphtheria-Tetanus–Acellular Pertussis Vaccines in Children
Matthieu Domenech de Cellès, PhD; Pejman Rohani, PhD; Aaron A. King, PhD
JAMA Pediatr. 2019;173(6):588-594. doi:10.1001/jamapediatrics.2019.0711
This simulation study assesses the duration of immunity and the effectiveness of diphtheria-tetanus–acellular pertussis vaccines in US children.

Innovation in Genomic Data Sharing at the NIH

New England Journal of Medicine
June 6, 2019 Vol. 380 No. 23
http://www.nejm.org/toc/nejm/medical-journal

 

Innovation in Genomic Data Sharing at the NIH
Bruce M. Psaty, M.D., Ph.D., Stephen S. Rich, Ph.D., and Eric Boerwinkle, Ph.D.
Major advances leveraging large-scale genomic and phenotype data require not only contemporary analytics based on deep learning and artificial intelligence, but also administrative and regulatory innovation.

Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries

PLoS Medicine
http://www.plosmedicine.org/
(Accessed 8 Jun 2019)

 

Policy Forum
Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries
Jonathon R. Campbell, David Dowdy, Kevin Schwartzman
| published 06 Jun 2019 PLOS Medicine
https://doi.org/10.1371/journal.pmed.1002824
Summary points
:: Tuberculosis (TB) persists in the United States, Canada, and other high-income, low- incidence countries largely because of ongoing reactivation of latent TB infection (LTBI).
:: TB elimination in low-incidence countries, defined as an annual incidence of ≤1 case per million, will require extensive screening and treatment of LTBI, including in people for whom the harms of LTBI treatment outweigh the likely benefits: for example, older foreign-born individuals with no recent travel/exposure. Ongoing migration from higher-incidence countries, as well as pockets of transmission in vulnerable subgroups such as prisoners, homeless persons, and drug users, will also continue to pose challenges for TB elimination.
:: Policymakers in low-incidence countries face a choice between a utilitarian approach that tolerates individual net harm to advance public health goals and a patient-centered approach that values shared decision-making but will predictably result in failure to achieve TB elimination.
:: While TB elimination is an important aspirational vision, the ethical implications of this goal—namely the implicit requirement to offer LTBI screening and treatment to individuals who are more likely to experience harm than good—merit careful reflection.

Science tikkun: A framework embracing the right of access to innovation and translational medicine on a global scale

PLoS Neglected Tropical Diseases
http://www.plosntds.org/
(Accessed 8 Jun 2019)

 

Editorial
Science tikkun: A framework embracing the right of access to innovation and translational medicine on a global scale
Peter J. Hotez
| published 06 Jun 2019 PLOS Neglected Tropical Diseases
https://doi.org/10.1371/journal.pntd.0007117
[See Milestones above for full text]

High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N?Djamena, Chad

PLoS One
http://www.plosone.org/
[Accessed 8 Jun 2019]

 

Research Article
High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N?Djamena, Chad
We conducted in 2018 a descriptive, quantitative, population-based, cross-sectional survey estimating the prevalence of cervical high-risk human papillomavirus (HR-HPV) infection and associated risk factors among adult women living in N’Djamena, Chad… These observations highlight the unsuspected high burden of cervical HR-HPV infection in Chadian women, and point the potential risk of further development of HPV-associated cervical precancerous and neoplastic lesions in a large proportion of women in Chad. The high rate of preventable Gardasil-9 vaccine genotypes constitutes the rationale for introducing primary vaccine prevention against cervical cancer in young female adolescents living in Chad.
Ralph-Sydney Mboumba Bouassa, Zita Aleyo Nodjikouambaye, Damtheou Sadjoli, Chatté Adawaye, Hélène Péré, David Veyer, Mathieu Matta, Leman Robin, Serge Tonen-Wolyec, Ali Mahamat Moussa, Donato Koyalta, Laurent Belec
Research Article | published 03 Jun 2019 PLOS ONE
https://doi.org/10.1371/journal.pone.0217486

Research on food-related chronic diseases in Latin America and the Caribbean: Are we building the evidence for gender-equitable approaches?

Revista Panamericana de Salud Pública/Pan American Journal of Public Health (RPSP/PAJPH)
http://www.paho.org/journal/index.php?option=com_content&view=featured&Itemid=101

 
7 Jun 2019
Research on food-related chronic diseases in Latin America and the Caribbean: Are we building the evidence for gender-equitable approaches?
Original research | English |

Strengthening institutional capacity for equitable health research: lessons from Latin America and the Caribbean

Revista Panamericana de Salud Pública/Pan American Journal of Public Health (RPSP/PAJPH)
http://www.paho.org/journal/index.php?option=com_content&view=featured&Itemid=101

 

 

7 Jun 2019
Strengthening institutional capacity for equitable health research: lessons from Latin America and the Caribbean
Opinion and analysis | Spanish | English | Portuguese |

Ethics of inclusion: Cultivate trust in precision medicine

Science
07 June 2019 Vol 364, Issue 6444
http://www.sciencemag.org/current.dtl

 

Policy Forum
Ethics of inclusion: Cultivate trust in precision medicine
By Sandra Soo-Jin Lee, Stephanie M. Fullerton, Aliya Saperstein, Janet K. Shim
Science07 Jun 2019 : 941-942 Restricted Access
We must explore how studies enhance diversity, inclusion
Summary
Precision medicine is at a crossroads. Progress toward its central goal, to address persistent health inequities, will depend on enrolling populations in research that have been historically underrepresented, thus eliminating longstanding exclusions from such research (1). Yet the history of ethical violations related to protocols for inclusion in biomedical research, as well as the continued misuse of research results (such as white nationalists looking to genetic ancestry to support claims of racial superiority), continue to engender mistrust among these populations (2). For precision medicine research (PMR) to achieve its goal, all people must believe that there is value in providing information about themselves and their families, and that their participation will translate into equitable distribution of benefits. This requires an ethics of inclusion that considers what constitutes inclusive practices in PMR, what goals and values are being furthered through efforts to enhance diversity, and who participates in adjudicating these questions. The early stages of PMR offer a critical window in which to intervene before research practices and their consequences become locked in (3).

Telemedicine infectious diseases consultations and clinical outcomes: a systematic review and meta-analysis protocol

Systematic Reviews
https://systematicreviewsjournal.biomedcentral.com/articles
[Accessed 8 Jun 2019]

 

Protocol
Telemedicine infectious diseases consultations and clinical outcomes: a systematic review and meta-analysis protocol
Telemedicine use is increasing in many specialties, but its impact on clinical outcomes in infectious diseases has not been systematically studied and reviewed. The proposed systematic review will evaluate the…
Authors: Jason P. Burnham, Stephanie A. Fritz, Lauren H. Yaeger and Graham A. Colditz
Citation: Systematic Reviews 2019 8:135
Published on: 7 June 2019